Literature DB >> 9358053

Upstream genomic sequence of the human connexin26 gene.

D T Kiang1, N Jin, Z J Tu, H H Lin.   

Abstract

Human connexin 26 (Cx26) has been considered to be a candidate suppressor gene in mammary epithelial cells. To gain insight into the transcriptional regulation of this gene, we have cloned and sequenced the 5' portion of the gene, which extends 4.8 kb upstream from the ATG translation start site. The 3' end of the non-coding exon 1 (160 bp) is located at 3149 bp upstream from the 5' end of exon 2. Comparison between the human Cx26 gene and the mouse gene reveals a highly conserved promoter region with 81% homology. In addition to six GC boxes and two GT boxes, a TTAAAA box is located at -24 to -19 bp upstream of the transcription start point. Analogous to the mouse beta-casein gene, the promoter region of the human Cx26 gene also contains a YY1-like binding site and a consensus mammary gland factor binding site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358053     DOI: 10.1016/s0378-1119(97)00365-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Connexin 26 35delG does not represent a mutational hotspot.

Authors:  Caryn R Rothrock; Alessandra Murgia; Edi L Sartorato; Emanuela Leonardi; Sainan Wei; Sarah L Lebeis; Laura E Yu; Jill L Elfenbein; Rachel A Fisher; Karen H Friderici
Journal:  Hum Genet       Date:  2003-04-09       Impact factor: 4.132

2.  Strategies for genetic study of hearing loss in the Brazilian northeastern region.

Authors:  Uirá S Melo; Silvana Santos; Hannalice G Cavalcanti; Wagner T Andrade; Vitor G Dantas; Marine Rd Rosa; Regina C Mingroni-Netto
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

3.  Expression of GJB2 and GJB6 is reduced in a novel DFNB1 allele.

Authors:  Ellen Wilch; Mei Zhu; Kirk B Burkhart; Martha Regier; Jill L Elfenbein; Rachel A Fisher; Karen H Friderici
Journal:  Am J Hum Genet       Date:  2006-05-17       Impact factor: 11.025

Review 4.  The noncoding genome and hearing loss.

Authors:  Karen B Avraham; Lama Khalaily; Yael Noy; Lara Kamal; Tal Koffler-Brill; Shahar Taiber
Journal:  Hum Genet       Date:  2021-09-07       Impact factor: 4.132

5.  Whole-Genome Sequencing Improves the Diagnosis of DFNB1 Monoallelic Patients.

Authors:  Anaïs Le Nabec; Mégane Collobert; Cédric Le Maréchal; Rémi Marianowski; Claude Férec; Stéphanie Moisan
Journal:  Genes (Basel)       Date:  2021-08-19       Impact factor: 4.096

6.  3D Chromatin Organization Involving MEIS1 Factor in the cis-Regulatory Landscape of GJB2.

Authors:  Anaïs Le Nabec; Clara Blotas; Alinéor Briset; Mégane Collobert; Claude Férec; Stéphanie Moisan
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

7.  A novel hearing-loss-related mutation occurring in the GJB2 basal promoter.

Authors:  T D Matos; H Caria; H Simões-Teixeira; T Aasen; R Nickel; D J Jagger; A O'Neill; D P Kelsell; G Fialho
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

8.  GJB2 c.-23+1G>A mutation is second most common mutation among Iranian individuals with autosomal recessive hearing loss.

Authors:  Sirous Zeinali; Elham Davoudi-Dehaghani; Sarah Azadmehr; Samira DabbaghBagheri; Hamideh Bagherian; Mojdeh Jamali; Fatemeh Zafarghandimotlagh; Mahboobeh Masoodifard; Ameneh BandehiSarhaddi; Leili Rejali; Sepideh Sahebi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-11       Impact factor: 2.503

9.  Characterization of GJB2 cis-regulatory elements in the DFNB1 locus.

Authors:  Stéphanie Moisan; Anaïs Le Nabec; Alicia Quillévéré; Cédric Le Maréchal; Claude Férec
Journal:  Hum Genet       Date:  2019-10-04       Impact factor: 4.132

10.  Assessing Noncoding Sequence Variants of GJB2 for Hearing Loss Association.

Authors:  T D Matos; H Simões-Teixeira; H Caria; R Cascão; H Rosa; A O'Neill; O Dias; M E Andrea; D P Kelsell; G Fialho
Journal:  Genet Res Int       Date:  2011-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.